zintick

Acumen Pharmaceuticals ABOS

Acumen Pharmaceuticals, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$2.29-3.78%close on Oct. 29, 2026 · volume 780K · Yahoo Finance

Price, last 48 sessions

$2.00$2.50$3.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 29, 2026 · high $3.18 · low $1.67 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 6 →
  • 8-KOct. 30, 2026, 7:06 a.m. ETView on SEC.govOur explainer

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedAcumen Pharmaceuticals (ABOS) Phase 2 ALTITUDE-AD Trial of Sabirnetug Misses Primary Endpoint; Company Ceases Development and Explores Strategic Options

  • 10-QOct. 26, 2026, 4:03 p.m. ETView on SEC.gov
  • 8-KOct. 26, 2026, 7:09 a.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedAcumen Pharmaceuticals (ABOS) Q3 2026: Net loss narrows to $25.4 million; cash and securities fall to $78.6 million, runway into early 2027

  • 8-KSept. 16, 2026, 9:26 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 10-QAug. 12, 2026, 4:13 p.m. ETView on SEC.gov
  • 8-KAug. 12, 2026, 7:02 a.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits